Mimer transforms how pharmaceutical companies develop medicine. Mimer analyzes genome and transcriptome data, along with research and public datasets, to find new gene interactions and drug targets. The Mimer platform offers a data-driven approach that reduces experimental costs and enhances reproducibility, ensuring robust and

reliable results.

M-Platform usespioneering technology to create personalized medical avatars predicting patient responses to medications with extensive biomedical data. It offers scalable, AI-driven healthcare by modeling over 13,500 diseases, initially focusing on breast, lung, lymphoma, and melanoma cancers.